Moderna, Inc.

MRNA

$220.70

per share, on-chain

What Moderna does

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Industry: Healthcare
CEO: Stéphane Bancel
Website: modernatx.com

Ways to own Moderna, Inc.

There are 2 versions of this stock. Same company; they differ in cost and in when they trade.

bStocksMRNABOur pick
Trades around the clock, from $1.
Backing is reported by Binance. A public report link isn't available yet.
$220.70
Open 24/7
OndoMRNAon
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$220.33
Closed until New York opens

Price check

What a slice looks like

$10.00 buys you 0.045 of one Moderna share.

That's 4.5% of one share. Small, but it's yours, and it moves with the real price. One share costs $220.70.